Separating Systemic Inflammation From Obesity in Load-Induced Osteoarthritis

区分负荷引起的骨关节炎中的全身炎症和肥胖

基本信息

  • 批准号:
    8885177
  • 负责人:
  • 金额:
    $ 20.33万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-03-01 至 2016-12-31
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): Osteoarthritis is classically defined as a non-inflammatory arthritis caused by excessive mechanical loading on the joint/cartilage. Osteoarthritis is also linked to obesity, which is commonly attributed to increased joint load caused by body weight. Multiple lines of evidence suggest that, in addition to mechanical loading, there are non-mechanical contributors to the development of osteoarthritis. Low-grade chronic systemic inflammation, associated with obesity and the metabolic syndrome, has been implicated as a non-mechanical contributor to osteoarthritis. However, the co-occurrence of obesity and systemic inflammation in most animal models and patients has so far made it difficult to separate the effects of the two factors on osteoarthritis. The proposed Exploratory/Developmental Research project is based on the hypothesis that low-grade chronic systemic inflammation originating in the gut enhances the adverse effects of mechanical load on the development of osteoarthritis. We propose separating the effects of systemic inflammation from obesity using the TLR5 deficient mouse, which spontaneously develops gut flora dysbiosis leading to gut inflammation, low-grade chronic systemic inflammation and a metabolic syndrome-like phenotype. Using a load-induced osteoarthritis model and the fact that inflammation in the TLR5 deficient mouse originates in the gut rather than from obesity, the project includes one aim: to determine the relationship between applied load magnitude and development of osteoarthritis in the TLR5 deficient mouse under three conditions: mild inflammation/mild increased body weight (natural state), mild inflammation/normal body weight (limit fed), and normal inflammation/normal body weight (antibiotic treated). Our findings will tes the idea that systemic inflammation influences susceptibility to osteoarthritis even in the absence of obesity and has the potential to provide the first evidence that changes in gut microbiota (the upstream cause of the TLR5KO phenotype) can influence susceptibility to osteoarthritis.
 描述(由适用提供):骨关节炎经典定义为关节/软骨上过多的机械负荷引起的非炎性关节炎。骨关节炎也与肥胖有关,这通常归因于体重引起的关节负荷增加。多种证据表明,除了机械载荷外,还有非机械性促进骨关节炎的贡献者。与肥胖症和代谢综合征有关的低级慢性全身性炎症已被实施为骨关节炎的非机械贡献者。然而,到目前为止,大多数动物模型和患者的肥胖和全身炎症的同时存在使这两个因素对骨关节炎的影响很难分开。拟议的探索性/发育研究项目基于以下假设:低级慢性全身性炎症起源于肠道,从而增强了机械负荷对骨关节炎发展的不利影响。我们建议使用TLR5缺乏小鼠将全身感染与肥胖的作用分开,该小鼠在赞助的情况下发展了肠道菌群营养不良,导致肠道注射,低度慢性全身感染和代谢综合征样表型。 Using a load-induced osteoarthritis model and the fact that inflammation in the TLR5 deficiency mouse originates in the gut rather than from observation, the project includes one aim: to determine the relationship between applied load magnitude and development of osteoarthritis in the TLR5 deficient mouse under three conditions: mild infection/mild increased body weight (natural state), mild infection/normal body weight (limit fed), and normal infection/normal body weight (抗生素治疗)。我们的发现将表明,即使没有肥胖症,系统感染也会影响骨关节炎的易感性,并有可能提供第一个证据,表明肠道菌群的变化(TLR5KO表型的上游原因)可能会影响对骨关节炎的易感性。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据

数据更新时间:2024-06-01

Christopher John H...的其他基金

The Microbiome and Bone Strength
微生物组和骨骼强度
  • 批准号:
    10211631
    10211631
  • 财政年份:
    2021
  • 资助金额:
    $ 20.33万
    $ 20.33万
  • 项目类别:
UCSF/UCB Joint Graduate Group in Bioengineering
UCSF/UCB 生物工程联合研究生小组
  • 批准号:
    10409636
    10409636
  • 财政年份:
    2021
  • 资助金额:
    $ 20.33万
    $ 20.33万
  • 项目类别:
The Microbiome and Bone Strength
微生物组和骨骼强度
  • 批准号:
    10854518
    10854518
  • 财政年份:
    2021
  • 资助金额:
    $ 20.33万
    $ 20.33万
  • 项目类别:
UCSF/UCB Joint Graduate Group in Bioengineering
UCSF/UCB 生物工程联合研究生小组
  • 批准号:
    10620339
    10620339
  • 财政年份:
    2021
  • 资助金额:
    $ 20.33万
    $ 20.33万
  • 项目类别:
The Microbiome and Bone Strength
微生物组和骨骼强度
  • 批准号:
    10405519
    10405519
  • 财政年份:
    2021
  • 资助金额:
    $ 20.33万
    $ 20.33万
  • 项目类别:
The Microbiome and Bone Strength
微生物组和骨骼强度
  • 批准号:
    10253532
    10253532
  • 财政年份:
    2020
  • 资助金额:
    $ 20.33万
    $ 20.33万
  • 项目类别:
The Role of Bone Resorption in Bone Marrow Lesions
骨吸收在骨髓病变中的作用
  • 批准号:
    9513670
    9513670
  • 财政年份:
    2018
  • 资助金额:
    $ 20.33万
    $ 20.33万
  • 项目类别:
Associations between gut microbiota, flagellin production and bone microstructure
肠道微生物群、鞭毛蛋白产生和骨微结构之间的关联
  • 批准号:
    8596224
    8596224
  • 财政年份:
    2013
  • 资助金额:
    $ 20.33万
    $ 20.33万
  • 项目类别:
Acquisition of a Nano Computed Tomography Instrument for shared Cornell Imaging f
购买纳米计算机断层扫描仪用于共享康奈尔成像 f
  • 批准号:
    8333738
    8333738
  • 财政年份:
    2013
  • 资助金额:
    $ 20.33万
    $ 20.33万
  • 项目类别:
Biomechanical Effects of Microstructural Flaws in Cancellous Bone
松质骨微观结构缺陷的生物力学效应
  • 批准号:
    8236928
    8236928
  • 财政年份:
    2010
  • 资助金额:
    $ 20.33万
    $ 20.33万
  • 项目类别:

相似国自然基金

基因与家庭不利环境影响儿童反社会行为的表观遗传机制:一项追踪研究
  • 批准号:
  • 批准年份:
    2020
  • 资助金额:
    58 万元
  • 项目类别:
    面上项目
不利地质结构对地下洞室群围岩地震响应影响研究
  • 批准号:
    51009131
  • 批准年份:
    2010
  • 资助金额:
    20.0 万元
  • 项目类别:
    青年科学基金项目
列车制动力对铁路桥梁的作用机理及最不利影响的研究
  • 批准号:
    50178004
  • 批准年份:
    2001
  • 资助金额:
    23.0 万元
  • 项目类别:
    面上项目

相似海外基金

Mechanisms and Selective Modulation of PPARy for the Treatment of Podocytopathies
PPARy 治疗足细胞病的机制和选择性调节
  • 批准号:
    10660400
    10660400
  • 财政年份:
    2023
  • 资助金额:
    $ 20.33万
    $ 20.33万
  • 项目类别:
The Role of the Adrb3/IL6 Axis in the Impact of Psychosocial Stress on Lupus Pathogenesis
Adrb3/IL6 轴在心理社会压力对狼疮发病机制影响中的作用
  • 批准号:
    10557799
    10557799
  • 财政年份:
    2022
  • 资助金额:
    $ 20.33万
    $ 20.33万
  • 项目类别:
The Role of the Adrb3/IL6 Axis in the Impact of Psychosocial Stress on Lupus Pathogenesis
Adrb3/IL6 轴在心理社会压力对狼疮发病机制影响中的作用
  • 批准号:
    10342034
    10342034
  • 财政年份:
    2022
  • 资助金额:
    $ 20.33万
    $ 20.33万
  • 项目类别:
Therapeutic Development of Osteogenic Oxysterol, Oxy133, for Spine Fusion
用于脊柱融合的成骨氧甾醇 (Oxy133) 的治疗开发
  • 批准号:
    10478295
    10478295
  • 财政年份:
    2021
  • 资助金额:
    $ 20.33万
    $ 20.33万
  • 项目类别:
Therapeutic Development of Osteogenic Oxysterol, Oxy133, for Spine Fusion
用于脊柱融合的成骨氧甾醇 (Oxy133) 的治疗开发
  • 批准号:
    10256352
    10256352
  • 财政年份:
    2021
  • 资助金额:
    $ 20.33万
    $ 20.33万
  • 项目类别: